Lifastuzumab Vedotin (SLC34A2) - Research Grade Biosimilar
Product Specifications
Background
Lifastuzumab vedotin is under investigation in clinical trial NCT01363947 (Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer) .
Immunogen
Humanized / SLC34A2 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Cancer
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-628
Fragment
IgG1-kappa
NCBI Organism
Homo sapiens
Other Product Names
DNIB0600A (conjugate), MNIB2126A (non conjugate)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
